FDA Grants AP Status for Succinylcholine Chloride ANDA217873
The FDA has granted approval status (AP) for ANDA217873, a generic formulation of Succinylcholine Chloride by STERISCIENCE.
Asset / Drug
Drug and asset intelligence for STERISCIENCE with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.